Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Catasys Inc (CATS) USD0.001

Sell:$25.68 Buy:$26.48 Change: $0.41 (1.61%)
NASDAQ:0.52%
Market closed |  Prices as at close on 2 July 2020 | Switch to live prices |
Sell:$25.68
Buy:$26.48
Change: $0.41 (1.61%)
Market closed |  Prices as at close on 2 July 2020 | Switch to live prices |
Sell:$25.68
Buy:$26.48
Change: $0.41 (1.61%)
Market closed |  Prices as at close on 2 July 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Catasys, Inc. is a provider of data analytics based specialized behavioral health management and treatment services to health plans through its OnTrak program. The Company's program utilizes member engagement and patient centric treatment that integrates evidence based medical and psychosocial interventions along with care coaching in a 52-week outpatient program. The Company operates through healthcare services segment. The healthcare services segment includes OnTrak and its integrated substance dependence solutions marketed to health plans, other third-party payers through a network of licensed, and Company managed healthcare providers. Its initial focus was on members with substance use disorders. It provides services to commercial (employer funded), managed Medicare Advantage and managed Medicaid populations. Its OnTrak substance dependence programs include medical and psychosocial interventions, psychosocial programs and integrated care-coaching services.

Contact details

Address:
2120 COLORADO AVE, SUITE 230
SANTA MONICA
90404
United States
Telephone:
+1 (310) 4444300
Website:
catasys.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CATS
ISIN:
US1490495041
Market cap:
$433.67 million
Shares in issue:
17.02 million
Sector:
Health Care Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Terren Peizer
    Chairman of the Board, Chief Executive Officer, Director
  • Curtis Medeiros
    President, Chief Operating Officer
  • Brandon LaVerne
    Chief Financial Officer
  • Daniel Prewitt
    Senior Vice President - Sales
  • Jeremiah Stone
    Chief Technology Officer
  • Carol Murdock
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.